Global Synthetic Cannabinoid 麻豆原创 Research Report 2023

Publication ID:

PB503235151

Publication Date:

March 10, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Specialty Chemicals [2]

Manufacturing (Chemicals) [3]

Chemicals [4]

Description:

Synthetic cannabinoids have become a new type of therapeutic drug for the treatment of epilepsy, spasticity, inflammation and so on.
The global Synthetic Cannabinoid market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Synthetic Cannabinoid is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Synthetic Cannabinoid is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Synthetic Cannabinoid include Noramco, Hyasynth Biologicals, Insys Therapeutics, CV Sciences, Ginkgo Bioworks, CannBioRx Life Sciences, Renew Biopharma and Lygos (Librede), etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Synthetic Cannabinoid, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Synthetic Cannabinoid.
The Synthetic Cannabinoid market size, estimations, and forecasts are provided in terms of output/shipments (Ton) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Synthetic Cannabinoid market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Synthetic Cannabinoid manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Noramco
Hyasynth Biologicals
Insys Therapeutics
CV Sciences
Ginkgo Bioworks
CannBioRx Life Sciences
Renew Biopharma
Lygos (Librede)
Segment by Type
High-Pure Synthetic Cannabinoid
Ultra-Pure Synthetic Cannabinoid
Segment by Application
Pharmaceutical
Consumer Good
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by type, by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Synthetic Cannabinoid manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Synthetic Cannabinoid by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Synthetic Cannabinoid in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Synthetic Cannabinoid 麻豆原创 Overview
1.1 Product Definition
1.2 Synthetic Cannabinoid Segment by Type
1.2.1 Global Synthetic Cannabinoid 麻豆原创 Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 High-Pure Synthetic Cannabinoid
1.2.3 Ultra-Pure Synthetic Cannabinoid
1.3 Synthetic Cannabinoid Segment by Application
1.3.1 Global Synthetic Cannabinoid 麻豆原创 Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Pharmaceutical
1.3.3 Consumer Good
1.3.4 Others
1.4 Global 麻豆原创 Growth Prospects
1.4.1 Global Synthetic Cannabinoid Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global Synthetic Cannabinoid Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global Synthetic Cannabinoid Production Estimates and Forecasts (2018-2029)
1.4.4 Global Synthetic Cannabinoid 麻豆原创 Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 麻豆原创 Competition by Manufacturers
2.1 Global Synthetic Cannabinoid Production 麻豆原创 Share by Manufacturers (2018-2023)
2.2 Global Synthetic Cannabinoid Production Value 麻豆原创 Share by Manufacturers (2018-2023)
2.3 Global Key Players of Synthetic Cannabinoid, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global Synthetic Cannabinoid 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Synthetic Cannabinoid Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of Synthetic Cannabinoid, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Synthetic Cannabinoid, Product Offered and Application
2.8 Global Key Manufacturers of Synthetic Cannabinoid, Date of Enter into This Industry
2.9 Synthetic Cannabinoid 麻豆原创 Competitive Situation and Trends
2.9.1 Synthetic Cannabinoid 麻豆原创 Concentration Rate
2.9.2 Global 5 and 10 Largest Synthetic Cannabinoid Players 麻豆原创 Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Synthetic Cannabinoid Production by Region
3.1 Global Synthetic Cannabinoid Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global Synthetic Cannabinoid Production Value by Region (2018-2029)
3.2.1 Global Synthetic Cannabinoid Production Value 麻豆原创 Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of Synthetic Cannabinoid by Region (2024-2029)
3.3 Global Synthetic Cannabinoid Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global Synthetic Cannabinoid Production by Region (2018-2029)
3.4.1 Global Synthetic Cannabinoid Production 麻豆原创 Share by Region (2018-2023)
3.4.2 Global Forecasted Production of Synthetic Cannabinoid by Region (2024-2029)
3.5 Global Synthetic Cannabinoid 麻豆原创 Price Analysis by Region (2018-2023)
3.6 Global Synthetic Cannabinoid Production and Value, Year-over-Year Growth
3.6.1 North America Synthetic Cannabinoid Production Value Estimates and Forecasts (2018-2029)
3.6.2 Europe Synthetic Cannabinoid Production Value Estimates and Forecasts (2018-2029)
3.6.3 China Synthetic Cannabinoid Production Value Estimates and Forecasts (2018-2029)
3.6.4 Japan Synthetic Cannabinoid Production Value Estimates and Forecasts (2018-2029)
4 Synthetic Cannabinoid Consumption by Region
4.1 Global Synthetic Cannabinoid Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global Synthetic Cannabinoid Consumption by Region (2018-2029)
4.2.1 Global Synthetic Cannabinoid Consumption by Region (2018-2023)
4.2.2 Global Synthetic Cannabinoid Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America Synthetic Cannabinoid Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America Synthetic Cannabinoid Consumption by Country (2018-2029)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Synthetic Cannabinoid Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe Synthetic Cannabinoid Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Synthetic Cannabinoid Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific Synthetic Cannabinoid Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Synthetic Cannabinoid Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa Synthetic Cannabinoid Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Synthetic Cannabinoid Production by Type (2018-2029)
5.1.1 Global Synthetic Cannabinoid Production by Type (2018-2023)
5.1.2 Global Synthetic Cannabinoid Production by Type (2024-2029)
5.1.3 Global Synthetic Cannabinoid Production 麻豆原创 Share by Type (2018-2029)
5.2 Global Synthetic Cannabinoid Production Value by Type (2018-2029)
5.2.1 Global Synthetic Cannabinoid Production Value by Type (2018-2023)
5.2.2 Global Synthetic Cannabinoid Production Value by Type (2024-2029)
5.2.3 Global Synthetic Cannabinoid Production Value 麻豆原创 Share by Type (2018-2029)
5.3 Global Synthetic Cannabinoid Price by Type (2018-2029)
6 Segment by Application
6.1 Global Synthetic Cannabinoid Production by Application (2018-2029)
6.1.1 Global Synthetic Cannabinoid Production by Application (2018-2023)
6.1.2 Global Synthetic Cannabinoid Production by Application (2024-2029)
6.1.3 Global Synthetic Cannabinoid Production 麻豆原创 Share by Application (2018-2029)
6.2 Global Synthetic Cannabinoid Production Value by Application (2018-2029)
6.2.1 Global Synthetic Cannabinoid Production Value by Application (2018-2023)
6.2.2 Global Synthetic Cannabinoid Production Value by Application (2024-2029)
6.2.3 Global Synthetic Cannabinoid Production Value 麻豆原创 Share by Application (2018-2029)
6.3 Global Synthetic Cannabinoid Price by Application (2018-2029)
7 Key Companies Profiled
7.1 Noramco
7.1.1 Noramco Synthetic Cannabinoid Corporation Information
7.1.2 Noramco Synthetic Cannabinoid Product Portfolio
7.1.3 Noramco Synthetic Cannabinoid Production, Value, Price and Gross Margin (2018-2023)
7.1.4 Noramco Main Business and 麻豆原创s Served
7.1.5 Noramco Recent Developments/Updates
7.2 Hyasynth Biologicals
7.2.1 Hyasynth Biologicals Synthetic Cannabinoid Corporation Information
7.2.2 Hyasynth Biologicals Synthetic Cannabinoid Product Portfolio
7.2.3 Hyasynth Biologicals Synthetic Cannabinoid Production, Value, Price and Gross Margin (2018-2023)
7.2.4 Hyasynth Biologicals Main Business and 麻豆原创s Served
7.2.5 Hyasynth Biologicals Recent Developments/Updates
7.3 Insys Therapeutics
7.3.1 Insys Therapeutics Synthetic Cannabinoid Corporation Information
7.3.2 Insys Therapeutics Synthetic Cannabinoid Product Portfolio
7.3.3 Insys Therapeutics Synthetic Cannabinoid Production, Value, Price and Gross Margin (2018-2023)
7.3.4 Insys Therapeutics Main Business and 麻豆原创s Served
7.3.5 Insys Therapeutics Recent Developments/Updates
7.4 CV Sciences
7.4.1 CV Sciences Synthetic Cannabinoid Corporation Information
7.4.2 CV Sciences Synthetic Cannabinoid Product Portfolio
7.4.3 CV Sciences Synthetic Cannabinoid Production, Value, Price and Gross Margin (2018-2023)
7.4.4 CV Sciences Main Business and 麻豆原创s Served
7.4.5 CV Sciences Recent Developments/Updates
7.5 Ginkgo Bioworks
7.5.1 Ginkgo Bioworks Synthetic Cannabinoid Corporation Information
7.5.2 Ginkgo Bioworks Synthetic Cannabinoid Product Portfolio
7.5.3 Ginkgo Bioworks Synthetic Cannabinoid Production, Value, Price and Gross Margin (2018-2023)
7.5.4 Ginkgo Bioworks Main Business and 麻豆原创s Served
7.5.5 Ginkgo Bioworks Recent Developments/Updates
7.6 CannBioRx Life Sciences
7.6.1 CannBioRx Life Sciences Synthetic Cannabinoid Corporation Information
7.6.2 CannBioRx Life Sciences Synthetic Cannabinoid Product Portfolio
7.6.3 CannBioRx Life Sciences Synthetic Cannabinoid Production, Value, Price and Gross Margin (2018-2023)
7.6.4 CannBioRx Life Sciences Main Business and 麻豆原创s Served
7.6.5 CannBioRx Life Sciences Recent Developments/Updates
7.7 Renew Biopharma
7.7.1 Renew Biopharma Synthetic Cannabinoid Corporation Information
7.7.2 Renew Biopharma Synthetic Cannabinoid Product Portfolio
7.7.3 Renew Biopharma Synthetic Cannabinoid Production, Value, Price and Gross Margin (2018-2023)
7.7.4 Renew Biopharma Main Business and 麻豆原创s Served
7.7.5 Renew Biopharma Recent Developments/Updates
7.8 Lygos (Librede)
7.8.1 Lygos (Librede) Synthetic Cannabinoid Corporation Information
7.8.2 Lygos (Librede) Synthetic Cannabinoid Product Portfolio
7.8.3 Lygos (Librede) Synthetic Cannabinoid Production, Value, Price and Gross Margin (2018-2023)
7.8.4 Lygos (Librede) Main Business and 麻豆原创s Served
7.7.5 Lygos (Librede) Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Synthetic Cannabinoid Industry Chain Analysis
8.2 Synthetic Cannabinoid Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Synthetic Cannabinoid Production Mode & Process
8.4 Synthetic Cannabinoid Sales and 麻豆原创ing
8.4.1 Synthetic Cannabinoid Sales Channels
8.4.2 Synthetic Cannabinoid Distributors
8.5 Synthetic Cannabinoid Customers
9 Synthetic Cannabinoid 麻豆原创 Dynamics
9.1 Synthetic Cannabinoid Industry Trends
9.2 Synthetic Cannabinoid 麻豆原创 Drivers
9.3 Synthetic Cannabinoid 麻豆原创 Challenges
9.4 Synthetic Cannabinoid 麻豆原创 Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 麻豆原创 Size Estimation
11.1.3 麻豆原创 Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer

Companies Mentioned:

Noramco
Hyasynth Biologicals
Insys Therapeutics
CV Sciences
Ginkgo Bioworks
CannBioRx Life Sciences
Renew Biopharma
Lygos (Librede)

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.